| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/19/2009 | EP1362096B1 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/19/2009 | EP1339425B1 Vaccine composition containing transforming growth factor alpha |
| 08/19/2009 | EP1287349B1 Method and apparatus for monitoring anti-platelet agents |
| 08/19/2009 | EP1280566B1 Growth factor modified protein matrices for tissue engineering |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1187918B9 Tek antagonists |
| 08/19/2009 | EP1131424B1 Mutation of the parkin gene, compositions, methods and uses |
| 08/19/2009 | EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis |
| 08/19/2009 | EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses |
| 08/19/2009 | EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 08/19/2009 | EP0744409B9 Platelet growth accelerator |
| 08/19/2009 | CN101512336A Stimulation of pancreatic beta cell proliferation |
| 08/19/2009 | CN101511868A Exendin fusion proteins |
| 08/19/2009 | CN101511867A Cytokine derivatives |
| 08/19/2009 | CN101511859A Use of proteins and peptides of the TGF-beta superfamily for purification and therapeutic methods |
| 08/19/2009 | CN101511823A Multifunctional bioactive compounds |
| 08/19/2009 | CN101511391A N-terminal derivatisation of proteins with polysaccharides |
| 08/19/2009 | CN101511383A Use of WNT5A for inhibiting scarring |
| 08/19/2009 | CN101511382A Selectively targeted antimicrobial peptides and the use thereof |
| 08/19/2009 | CN101511381A Methods of treating obesity using satiety factors |
| 08/19/2009 | CN101511380A Pharmaceutical compositions for sustained release delivery of peptides |
| 08/19/2009 | CN101511379A Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 08/19/2009 | CN101511181A Proteins, nucleic acids encoding the same and associated methods of use |
| 08/19/2009 | CN101509011A Carrier containing immunoglobulinlg gene, construction method and uses thereof |
| 08/19/2009 | CN101508993A Bullfrog lectin gene, encoded lectin and uses thereof |
| 08/19/2009 | CN101508982A Deoxyribozyme for effective degradation of esoderma native-1mRNA and uses in reducing acute ischemic arrhythmia |
| 08/19/2009 | CN101508731A Trichinella spiralis and tumor-associated antigen protein, preparation and medical use thereof |
| 08/19/2009 | CN101508722A Novel antihypertensive peptide and use thereof |
| 08/19/2009 | CN101507822A Reduction of dermal scarring |
| 08/19/2009 | CN101507811A Wound healing agent and composition |
| 08/19/2009 | CN101507712A Sustained-release micro-spheres preparation containing recombined erythropoietin and preparation method and use thereof |
| 08/19/2009 | CN101507709A Interleukin -2 liposome and preparation method thereof |
| 08/19/2009 | CN101507706A Biodegradable in-situ solidification sustained-release injector |
| 08/19/2009 | CN101507494A Special diet food for patient with hyperlipidemia and hypertension |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100529067C Bamboo leaf SOD preparation method |
| 08/19/2009 | CN100529063C Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 08/19/2009 | CN100528899C Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 08/19/2009 | CN100528898C High purity ulinastatin and its prepn process and medicine composition |
| 08/19/2009 | CN100528897C Modified soluble t cell receptor |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/19/2009 | CN100528230C Recombination human MUC1-MBP fusion protein antitumour vaccine and production technology |
| 08/19/2009 | CN100528224C Slow release microphere for injection containing interferon alpha-1b and its preparation method |
| 08/19/2009 | CN100528223C Skin collagen production promoter |
| 08/19/2009 | CN100528222C Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 08/19/2009 | CN100528221C Anti-hepatitis B virus medicine agent and its preparing process |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/19/2009 | CN100528145C Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 08/18/2009 | USRE40876 Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof |
| 08/18/2009 | US7576323 Point-of-care mass spectrometer system |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576194 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection; for immunodiagnosis and immunoprophylaxis |
| 08/18/2009 | US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 08/18/2009 | US7576190 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome |
| 08/18/2009 | US7576189 antibodies against such VEGFs, which may be used to inhibit their action, for example, to inhibit the growth of tumors, to treat diabetic retinopathy, rheumatoid arthritis and psoriasis |
| 08/18/2009 | US7576188 Antitumoral treatments |
| 08/18/2009 | US7576184 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 08/18/2009 | US7576183 Structure-based receptor MIMICS targeted against bacterial superantigen toxins |
| 08/18/2009 | US7576181 Method of administering porcine B-domainless fVIII |
| 08/18/2009 | US7576180 Opioid growth factor receptors |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576177 Heat shock proteins (HSP) activate lymphocytes to produce immunomodulatory cytokines and influence cytokines, chemokines, and surface antigens; drug screening |
| 08/18/2009 | US7576176 Neisseria meningitidis antigens and compositions |
| 08/18/2009 | US7576175 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 08/18/2009 | US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents |
| 08/18/2009 | US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576071 Antithrombotic compound |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576066 Administering nucleic acid to stimunlate immunology response |
| 08/18/2009 | US7576065 Administering the neurotrophic factor and the inhibitor into the lateral ventricles or ventricular wall to induce neuronal production in the brain and spinal cord of the subject;. suppressing astrocyte generation; neurodegenerative diseases |
| 08/18/2009 | US7576062 Compounds with growth hormone releasing properties |
| 08/18/2009 | US7576061 Methods for preventing mitochondrial permeability transition |
| 08/18/2009 | US7576060 Inhibition of adhesion and migration of an endothelial cell to fibronectin by neutrophil alpha-defensins |
| 08/18/2009 | US7576059 Peptide derivatives |
| 08/18/2009 | US7576058 Method for importing biologically active molecules into cells |
| 08/18/2009 | US7576057 Cyclic peptides |
| 08/18/2009 | US7576056 Peptides and compounds that bind to a receptor |
| 08/18/2009 | US7576055 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 08/18/2009 | US7576054 Administering a synergistic mixture containsing 6% nisin and 2% mupirocin for killing/inhibiting growth of Staphylococcus aureus |
| 08/18/2009 | US7576053 Methods and compositions for treating degenerative bone disorders |
| 08/18/2009 | US7576052 Methods and compositions for modulating adipocyte function |
| 08/18/2009 | US7576051 Polypeptide with epidermal regeneration-accelerating minimal amino acid sequences, a polyalkylenepolyamine and/or polyarylenepolyamine, and a sheet |
| 08/18/2009 | US7576050 Glucagon-like peptides and ependins for use in treatment and prevention of diabetes and neurodegenerative conditions; neuroprotective agents; neurotrophic factors |
| 08/18/2009 | US7575929 Diagnosis of multiple sclerosis with diketopiperazines |
| 08/18/2009 | US7575923 CD19xCD3 specific polypeptides and uses thereof |
| 08/18/2009 | US7575922 Polypeptide and gene encoding the same |
| 08/18/2009 | US7575918 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 08/18/2009 | US7575916 Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid molecule |
| 08/18/2009 | US7575894 Human recombinant beta-interferon with improved solubility |
| 08/18/2009 | US7575891 Process for production of diphtheria toxin |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |
| 08/18/2009 | US7575876 Biomarkers for neurodegenerative disorders |
| 08/18/2009 | US7575857 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy |
| 08/18/2009 | US7575758 Controlling acarine pests by applying an isolated polypeptide to locus of acarine pests, wherein polypeptide is an omega-ACTX peptide; polypeptide toxin comprises three intrachain disulfide bonds and/or is a component of a venom of an Australian funnel web spider of genus Atrax or Hadronyche |
| 08/18/2009 | US7575755 Method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as "GPI") inositolglycan domain or its derivative or equivalent |